Callaghan MU, Negrier C, Paz-Priel I, et al. Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies. Blood. 2021;137(16):2231-2242.

Publikováno v: In Blood 12 October 2023 142(15):1329-1329

Performance of a recombinant fusion protein linking coagulation factor IX with recombinant albumin in one‐stage clotting assays

Autor: Horn, C., Négrier, C., Kalina, U., Seifert, W., Friedman, K.D. ^*

Publikováno v: In Journal of Thrombosis and Haemostasis January 2019 17(1):138-148

Postauthorization safety study of Clottafact^®, a triply secured fibrinogen concentrate in acquired fibrinogen deficiency: a prospective observational study.

Autor: Négrier, C.¹, Ducloy‐Bouthors, A.‐S.², Piriou, V.³, De Maistre, E.⁴, Stieltjes, N.⁵, Borel‐Derlon, A.⁶, Colson, P.⁷, Picard, J.⁸, Lambert, T.⁹, Claeyssens, S.¹⁰, Boileau, S.¹¹, Bertrand, A.¹², André, M.‐H.¹², Fourrier, F.², Ozier, Y.¹³, Sié, P.¹⁴, Gruel, Y.¹⁵, Tellier, Z.¹² tellier@lfb.fr

Publikováno v: Vox Sanguinis. Feb2018, Vol. 113 Issue 2, p120-127. 8p. 5 Charts.

PHAREO study: Perceived and observed accessibility to therapeutic drugs used for treating patients with inherited bleeding disorders.

Autor: Chamouard V; Centre de Référence de l'Hémophilie et autres déficits constitutionnels en protéines de la coagulation, Hôpital Louis Pradel, Groupement Hospitalier Est, Bron, France.; Service pharmaceutique, Hôpital Louis Pradel, Groupement Hospitalier Est, Bron, France., Fraticelli L; RESCUe-RESUVal, Centre Hospitalier Lucien Hussel, Montée Docteur Maurice Chapuis, Vienne, France.; Laboratoire Parcours Santé Systémique (P2S) UR 4129, Université de Lyon 1, Lyon, France., Freyssenge J; RESCUe-RESUVal, Centre Hospitalier Lucien Hussel, Montée Docteur Maurice Chapuis, Vienne, France.; Research On Healthcare Performance (RESHAPE), INSERM, Lyon, France., Claustre C; RESCUe-RESUVal, Centre Hospitalier Lucien Hussel, Montée Docteur Maurice Chapuis, Vienne, France., Négrier C; Centre de Référence de l'Hémophilie et autres déficits constitutionnels en protéines de la coagulation, Hôpital Louis Pradel, Groupement Hospitalier Est, Bron, France., El Khoury C; RESCUe-RESUVal, Centre Hospitalier Lucien Hussel, Montée Docteur Maurice Chapuis, Vienne, France.; Clinical Research Unit, Médipôle Hôpital Mutualiste, Villeurbanne, France.

Publikováno v: Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2022 Oct; Vol. 47 (10), pp. 1667-1675. Date of Electronic Publication: 2022 Jun 20.

Prophylaxis with a recombinant factor VIII Fc in hemophilia A: long-term follow-up on joint health, efficacy, and safety from phase 3 studies in children and adults.

Autor: Konkle BA; Washington Center for Bleeding Disorders, Seattle, Washington, USA.; Division of Hematology, University of Washington, Seattle, Washington, USA., Oldenburg J; Institute of Experimental Hematology and Transfusion Medicine University Clinic Bonn, Bonn, Germany., Pasi J; Royal London Haemophilia Centre, Barts and the London School of Medicine and Dentistry, London, UK., Kulkarni R; Department of Pediatrics and Human Development, Michigan State University, East Lansing, Michigan, USA., Nolan B; Children's Health Ireland at Crumlin, Dublin, Ireland., Mahlangu J; Hemophilia Comprehensive Care Centre, Department of Molecular Medicine and Hematology, Faculty of Health Sciences, University of the Witwatersrand and National Health Laboratory Service, Johannesburg, South Africa., Young G; Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, California, USA., Brown SA; Queensland Children's Hospital, Brisbane, QLD, Australia., Pabinger I; Clinical Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Shapiro A; Indiana Hemophilia & Thrombosis Center, Indianapolis, Indiana, USA., Négrier C; Division of Hematology, University Claude Bernard Lyon I, Lyon, France., Blanchette V; Department of Pediatrics and Child Health Evaluative Sciences, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Ragni MV; Department of Medicine, Division of Hematology/Oncology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Dumont J; Sanofi, Waltham, Massachusetts, USA., Lethagen S; Swedish Orphan Biovitrum AB, Stockholm, Sweden.; Copenhagen University, Copenhagen, Denmark.

Publikováno v: Research and practice in thrombosis and haemostasis [Res Pract Thromb Haemost] 2023 Aug 22; Vol. 7 (6), pp. 102180. Date of Electronic Publication: 2023 Aug 22 (Print Publication: 2023).